drugset / Trial / NCT02392286

Corticosteroid Dosage for Crohn's Disease Flare

NCT02392286

Phase 4 Terminated 15 enrolled Yale University
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective randomized comparative effectiveness trial designed to compare fixed dosing and weight-based dosing of corticosteroids in patients with Crohn's disease flares.

Timeline

Start
2015-03
Primary completion
2016-12-19
Completion
2016-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 1 mg/kg Oral
Subject Prednisone Other / unclassified 40 mg Oral
Background Methylprednisolone Other / unclassified Intravenous

Indications